Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1997 1
1998 5
1999 6
2000 3
2001 13
2002 6
2003 17
2004 7
2005 16
2006 27
2007 32
2008 22
2009 25
2010 35
2011 41
2012 46
2013 43
2014 42
2015 32
2016 34
2017 40
2018 20
2019 27
2020 24
2021 18
2022 7
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

PubMed (MeSH Keyword) for id: 5281104

529 results

Results by year

Filters applied: . Clear all
Page 1
Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients.
Uriol-Rivera MG, Obrador-Mulet A, Juliá MR, Daza-Cajigal V, Delgado-Sanchez O, Garcia Alvarez A, Gomez-Lobon A, Carrillo-Garcia P, Saus-Sarrias C, Gómez-Cobo C, Ramis-Cabrer D, Gasco Company J, Molina-Infante J; Balear IgA Research and Treatment Project. Uriol-Rivera MG, et al. Sci Rep. 2024 Feb 28;14(1):4866. doi: 10.1038/s41598-024-55425-7. Sci Rep. 2024. PMID: 38418932 Free PMC article.
The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials.
Arabi SM, Shahraki-Jazinaki M, Chambari M, Bahrami LS, Sabeti S, Gubari MIM, Roufogalis BD, Sahebkar A. Arabi SM, et al. BMC Pharmacol Toxicol. 2024 Feb 23;25(1):19. doi: 10.1186/s40360-024-00740-y. BMC Pharmacol Toxicol. 2024. PMID: 38395972 Free PMC article.
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.
Mujalli A, Farrash WF, Obaid AA, Khan AA, Almaimani RA, Idris S, Elzubier ME, Khidir EBA, Aslam A, Minshawi F, Alobaidy MA, Alharbi AB, Almasmoum HA, Ghaith M, Alqethami K, Refaat B. Mujalli A, et al. Int J Mol Sci. 2023 Dec 12;24(24):17380. doi: 10.3390/ijms242417380. Int J Mol Sci. 2023. PMID: 38139208 Free PMC article.
529 results